Evaluation of growth and development of patients with Down syndrome in Santiago de Cuba
Keywords:
Down syndrome, congenital defect, anthropometric index, growth and development pattern.Abstract
A descriptive, cross-sectional and quantitative study of 54 patients with Down syndrome, assisted in the Clinical Genetics Service of “Dr. Antonio María Béguez César” Teaching Southern Children Hospital was carried out in Santiago de Cuba, from 2000 to 2015, aimed at determining the growth pattern of those affected patients. Among the analyzed variables there were age, sex and anthropometric indexes: weight according to age, height according to age, weight/height index and body mass index; also, the most frequent congenital defects were evaluated in the sample. It was concluded that the growth pattern of these patients is similar to the one described in the medical literature related to the topic, which can be useful for the clinical care that should be offered, as well as to guide the parents on the eating habits and lifestyles as part of the treatment of children and adolescents with this syndrome.
Downloads
References
2. Pérez Mateo MT, Fuentes Smith LE. Experiencia de veinte años del Registro Cubano de Malformaciones Congénitas. Rev Cubana Genet Comunit. 2007;1(2):28-34.
3. Martínez Rubio A, Riverón Forment G, Pupo Balboa J, Lantigua Cruz A, Martínez Bonne O. Evaluación de marcadores de estrés oxidativo en pacientes con síndrome Down en edad pediátrica. Rev Cubana Genet Comunit. 2010; 4(1): 23-8.
4. Garduño Zarazúa LM, Giammatteo Aloi L, Kofman Epstein S, Cervantes Peredo AB. Prevalencia de mosaicismo para la trisomía 21 y análisis de las variantes citogenéticas en pacientes diagnosticados de síndrome de Down. Revisión de 24 años (1986-2010) del Servicio de Genética del Hospital General de México “Dr. Eduardo Liceaga”. Bol Med Hosp Infant Mex. 2013; 70(1):31-7.
5. Lantigua Cruz A. Introducción a la genética médica. La Habana. ECIMED; 2011.
6. Taboada Lugo N, Licea Rodríguez MA, Acosta Camacho O, Pérez Estévez O, Díaz Seranega R, Rodríguez Vivar JL, et al. Caracterización etiológica clínica y genética del síndrome Down en el Estado Plurinacional de Bolivia. Rev Cubana Genet Comunit. 2011; 5(2-3):82-8.
7. Strydom A, Dickinson MJ, Shende S, Pratico D, Walker Z. Oxidative stress and cognitive ability in adults with Down syndrome. Prog Neuropsychopharmacol Biolog Psychiatry. 2009;33(1):76-80.
8. León Ojeda NE de, Pérez Mateo MT, Estévez Perera A, García García A, García Martínez D. Defectos cardiovasculares congénitos en niños cubanos con síndrome de Down. Rev Cubana Genet Comunit. 2008; 2(1):14-21.
9. Jiménez L, Cerda J, Albert G, Lazama M. Malnutrición por exceso: alta frecuencia de sobrepeso y obesidad en escolares chilenos con síndrome Down. Rev Med Chile. 2015 [citado 22 Jul 2016]; 143(4): 451-8. Disponible en: http://www.scielo.cl/scielo.php?script=sci_arttext&pid=S0034-98872015000400006
10. Peña Rivera AG, Vázquez Garibay EM, Troyo Sanromán R, Romero Velarde E, Caro Sabido E, Ramírez Díaz J. The distribution of the indicator height for age of Mexican children and adolescents with Down síndrome according to different reference standars. Nutr Hosp. 2015 [citado 22 Jul 2016]; 31(6): 2472-8. Disponible en: https://www.ncbi.nlm.nih.gov/pubmed/26040354
11. Gutiérrez Muñiz JA, Berdasco Gómez A, Esquivel Lauzurrique M, Jiménez Hernández JM, Posada Lima E, Romero del Sol JM, et al. Crecimiento y desarrollo. En: Pediatría. T 1. La Habana: ECIMED; 2006.p. 27-58.
12. Leis R, Tojo R. Valoración del crecimiento. En: Cruz M. Tratado de Pediatría. 9 ed. Madrid: Editorial Ergon; 2006.p. 856-64.
13. Llanio Navarro R, Lantigua Cruz A, Batule Batule M, Matarama Peñate M, Arús Soler E, Fernández Naranjo A, et al. Síndromes. La Habana: ECIMED; 2005.p. 454.
14. Amador García M, Peña Escobar M, Hermelo Treche M, Martínez González A. Obesidad. En: Pediatría. T1. La Habana: ECIMED; 2006.p.264- 72.
Published
How to Cite
Issue
Section
License
All the articles can be downloaded or read for free. The journal does not charge any amount of money to the authors for the reception, edition or the publication of the articles, making the whole process completely free. Medisan has no embargo period and it is published under the license of Creative Commons, International Non Commercial Recognition 4.0, which authorizes the copy, reproduction and the total or partial distribution of the articles in any format or platform, with the conditions of citing the source of information and not to be used for profitable purposes.